TNGX - Will more bidders emerge or CVR ever be paid in Mirati takeover deal?
2023-10-09 13:10:55 ET
More on Bristol-Myers Squibb Company , Mirati Therapeutics
- Bristol-Myers' Mirati Takeover: Pharma Is Either Buying Crown Jewels Or A Dud
- Bristol-Myers: Out Of Favor (Rating Upgrade)
- Bristol-Myers Squibb: How Cheap Is Cheap Enough?
- Mirati Therapeutics could see another bidder emerge, Leerink says
- 4 stocks to watch on Monday: Mirati Therapeutics, Arm Holdings and more
For further details see:
Will more bidders emerge or CVR ever be paid in Mirati takeover deal?